Global CAR-T Cell Therapy Solution Supply, Demand and Key Producers, 2023-2029

Global CAR-T Cell Therapy Solution Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 04 Apr 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global CAR-T Cell Therapy Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global CAR-T Cell Therapy Solution demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CAR-T Cell Therapy Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR-T Cell Therapy Solution that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CAR-T Cell Therapy Solution total market, 2018-2029, (USD Million)
Global CAR-T Cell Therapy Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CAR-T Cell Therapy Solution total market, key domestic companies and share, (USD Million)
Global CAR-T Cell Therapy Solution revenue by player and market share 2018-2023, (USD Million)
Global CAR-T Cell Therapy Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global CAR-T Cell Therapy Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CAR-T Cell Therapy Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Q2 Solutions, Agilent Technologies, Genscript Biotech, Sino Biological, Nuowei Biotechnology, Novartis, JW Therapeutics and Sorrento Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR-T Cell Therapy Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global CAR-T Cell Therapy Solution Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global CAR-T Cell Therapy Solution Market, Segmentation by Type
CD19 CAR Cell Therapy
BCMA CAR Cell Therapy

Global CAR-T Cell Therapy Solution Market, Segmentation by Application
Leukemia
Lymphoma
Myeloma
Others

Companies Profiled:
Thermo Fisher Scientific
Q2 Solutions
Agilent Technologies
Genscript Biotech
Sino Biological
Nuowei Biotechnology
Novartis
JW Therapeutics
Sorrento Therapeutics
Gilead Sciences

Key Questions Answered
1. How big is the global CAR-T Cell Therapy Solution market?
2. What is the demand of the global CAR-T Cell Therapy Solution market?
3. What is the year over year growth of the global CAR-T Cell Therapy Solution market?
4. What is the total value of the global CAR-T Cell Therapy Solution market?
5. Who are the major players in the global CAR-T Cell Therapy Solution market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 CAR-T Cell Therapy Solution Introduction
1.2 World CAR-T Cell Therapy Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CAR-T Cell Therapy Solution Total Market by Region (by Headquarter Location)
1.3.1 World CAR-T Cell Therapy Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.3 China CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.4 Europe CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.5 Japan CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.6 South Korea CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.7 ASEAN CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.8 India CAR-T Cell Therapy Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR-T Cell Therapy Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CAR-T Cell Therapy Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.2 World CAR-T Cell Therapy Solution Consumption Value by Region
2.2.1 World CAR-T Cell Therapy Solution Consumption Value by Region (2018-2023)
2.2.2 World CAR-T Cell Therapy Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.4 China CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.5 Europe CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.6 Japan CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.7 South Korea CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.8 ASEAN CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.9 India CAR-T Cell Therapy Solution Consumption Value (2018-2029)

3 World CAR-T Cell Therapy Solution Companies Competitive Analysis
3.1 World CAR-T Cell Therapy Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CAR-T Cell Therapy Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CAR-T Cell Therapy Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for CAR-T Cell Therapy Solution in 2022
3.3 CAR-T Cell Therapy Solution Company Evaluation Quadrant
3.4 CAR-T Cell Therapy Solution Market: Overall Company Footprint Analysis
3.4.1 CAR-T Cell Therapy Solution Market: Region Footprint
3.4.2 CAR-T Cell Therapy Solution Market: Company Product Type Footprint
3.4.3 CAR-T Cell Therapy Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: CAR-T Cell Therapy Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CAR-T Cell Therapy Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CAR-T Cell Therapy Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CAR-T Cell Therapy Solution Consumption Value Comparison
4.2.1 United States VS China: CAR-T Cell Therapy Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CAR-T Cell Therapy Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CAR-T Cell Therapy Solution Companies and Market Share, 2018-2023
4.3.1 United States Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023)
4.4 China Based Companies CAR-T Cell Therapy Solution Revenue and Market Share, 2018-2023
4.4.1 China Based CAR-T Cell Therapy Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023)
4.5 Rest of World Based CAR-T Cell Therapy Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World CAR-T Cell Therapy Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19 CAR Cell Therapy
5.2.2 BCMA CAR Cell Therapy
5.3 Market Segment by Type
5.3.1 World CAR-T Cell Therapy Solution Market Size by Type (2018-2023)
5.3.2 World CAR-T Cell Therapy Solution Market Size by Type (2024-2029)
5.3.3 World CAR-T Cell Therapy Solution Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World CAR-T Cell Therapy Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Leukemia
6.2.2 Lymphoma
6.2.3 Myeloma
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World CAR-T Cell Therapy Solution Market Size by Application (2018-2023)
6.3.2 World CAR-T Cell Therapy Solution Market Size by Application (2024-2029)
6.3.3 World CAR-T Cell Therapy Solution Market Size by Application (2018-2029)

7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific CAR-T Cell Therapy Solution Product and Services
7.1.4 Thermo Fisher Scientific CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Q2 Solutions
7.2.1 Q2 Solutions Details
7.2.2 Q2 Solutions Major Business
7.2.3 Q2 Solutions CAR-T Cell Therapy Solution Product and Services
7.2.4 Q2 Solutions CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Q2 Solutions Recent Developments/Updates
7.2.6 Q2 Solutions Competitive Strengths & Weaknesses
7.3 Agilent Technologies
7.3.1 Agilent Technologies Details
7.3.2 Agilent Technologies Major Business
7.3.3 Agilent Technologies CAR-T Cell Therapy Solution Product and Services
7.3.4 Agilent Technologies CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Agilent Technologies Recent Developments/Updates
7.3.6 Agilent Technologies Competitive Strengths & Weaknesses
7.4 Genscript Biotech
7.4.1 Genscript Biotech Details
7.4.2 Genscript Biotech Major Business
7.4.3 Genscript Biotech CAR-T Cell Therapy Solution Product and Services
7.4.4 Genscript Biotech CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Genscript Biotech Recent Developments/Updates
7.4.6 Genscript Biotech Competitive Strengths & Weaknesses
7.5 Sino Biological
7.5.1 Sino Biological Details
7.5.2 Sino Biological Major Business
7.5.3 Sino Biological CAR-T Cell Therapy Solution Product and Services
7.5.4 Sino Biological CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sino Biological Recent Developments/Updates
7.5.6 Sino Biological Competitive Strengths & Weaknesses
7.6 Nuowei Biotechnology
7.6.1 Nuowei Biotechnology Details
7.6.2 Nuowei Biotechnology Major Business
7.6.3 Nuowei Biotechnology CAR-T Cell Therapy Solution Product and Services
7.6.4 Nuowei Biotechnology CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Nuowei Biotechnology Recent Developments/Updates
7.6.6 Nuowei Biotechnology Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis CAR-T Cell Therapy Solution Product and Services
7.7.4 Novartis CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 JW Therapeutics
7.8.1 JW Therapeutics Details
7.8.2 JW Therapeutics Major Business
7.8.3 JW Therapeutics CAR-T Cell Therapy Solution Product and Services
7.8.4 JW Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 JW Therapeutics Recent Developments/Updates
7.8.6 JW Therapeutics Competitive Strengths & Weaknesses
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Details
7.9.2 Sorrento Therapeutics Major Business
7.9.3 Sorrento Therapeutics CAR-T Cell Therapy Solution Product and Services
7.9.4 Sorrento Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sorrento Therapeutics Recent Developments/Updates
7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
7.10 Gilead Sciences
7.10.1 Gilead Sciences Details
7.10.2 Gilead Sciences Major Business
7.10.3 Gilead Sciences CAR-T Cell Therapy Solution Product and Services
7.10.4 Gilead Sciences CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Gilead Sciences Recent Developments/Updates
7.10.6 Gilead Sciences Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 CAR-T Cell Therapy Solution Industry Chain
8.2 CAR-T Cell Therapy Solution Upstream Analysis
8.3 CAR-T Cell Therapy Solution Midstream Analysis
8.4 CAR-T Cell Therapy Solution Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World CAR-T Cell Therapy Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CAR-T Cell Therapy Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CAR-T Cell Therapy Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CAR-T Cell Therapy Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CAR-T Cell Therapy Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CAR-T Cell Therapy Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CAR-T Cell Therapy Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CAR-T Cell Therapy Solution Players in 2022
Table 12. World CAR-T Cell Therapy Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CAR-T Cell Therapy Solution Company Evaluation Quadrant
Table 14. Head Office of Key CAR-T Cell Therapy Solution Player
Table 15. CAR-T Cell Therapy Solution Market: Company Product Type Footprint
Table 16. CAR-T Cell Therapy Solution Market: Company Product Application Footprint
Table 17. CAR-T Cell Therapy Solution Mergers & Acquisitions Activity
Table 18. United States VS China CAR-T Cell Therapy Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CAR-T Cell Therapy Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CAR-T Cell Therapy Solution Revenue Market Share (2018-2023)
Table 23. China Based CAR-T Cell Therapy Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CAR-T Cell Therapy Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CAR-T Cell Therapy Solution Revenue Market Share (2018-2023)
Table 29. World CAR-T Cell Therapy Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CAR-T Cell Therapy Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World CAR-T Cell Therapy Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World CAR-T Cell Therapy Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CAR-T Cell Therapy Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World CAR-T Cell Therapy Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific CAR-T Cell Therapy Solution Product and Services
Table 38. Thermo Fisher Scientific CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Q2 Solutions Basic Information, Area Served and Competitors
Table 42. Q2 Solutions Major Business
Table 43. Q2 Solutions CAR-T Cell Therapy Solution Product and Services
Table 44. Q2 Solutions CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Q2 Solutions Recent Developments/Updates
Table 46. Q2 Solutions Competitive Strengths & Weaknesses
Table 47. Agilent Technologies Basic Information, Area Served and Competitors
Table 48. Agilent Technologies Major Business
Table 49. Agilent Technologies CAR-T Cell Therapy Solution Product and Services
Table 50. Agilent Technologies CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Agilent Technologies Recent Developments/Updates
Table 52. Agilent Technologies Competitive Strengths & Weaknesses
Table 53. Genscript Biotech Basic Information, Area Served and Competitors
Table 54. Genscript Biotech Major Business
Table 55. Genscript Biotech CAR-T Cell Therapy Solution Product and Services
Table 56. Genscript Biotech CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Genscript Biotech Recent Developments/Updates
Table 58. Genscript Biotech Competitive Strengths & Weaknesses
Table 59. Sino Biological Basic Information, Area Served and Competitors
Table 60. Sino Biological Major Business
Table 61. Sino Biological CAR-T Cell Therapy Solution Product and Services
Table 62. Sino Biological CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sino Biological Recent Developments/Updates
Table 64. Sino Biological Competitive Strengths & Weaknesses
Table 65. Nuowei Biotechnology Basic Information, Area Served and Competitors
Table 66. Nuowei Biotechnology Major Business
Table 67. Nuowei Biotechnology CAR-T Cell Therapy Solution Product and Services
Table 68. Nuowei Biotechnology CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Nuowei Biotechnology Recent Developments/Updates
Table 70. Nuowei Biotechnology Competitive Strengths & Weaknesses
Table 71. Novartis Basic Information, Area Served and Competitors
Table 72. Novartis Major Business
Table 73. Novartis CAR-T Cell Therapy Solution Product and Services
Table 74. Novartis CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novartis Recent Developments/Updates
Table 76. Novartis Competitive Strengths & Weaknesses
Table 77. JW Therapeutics Basic Information, Area Served and Competitors
Table 78. JW Therapeutics Major Business
Table 79. JW Therapeutics CAR-T Cell Therapy Solution Product and Services
Table 80. JW Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. JW Therapeutics Recent Developments/Updates
Table 82. JW Therapeutics Competitive Strengths & Weaknesses
Table 83. Sorrento Therapeutics Basic Information, Area Served and Competitors
Table 84. Sorrento Therapeutics Major Business
Table 85. Sorrento Therapeutics CAR-T Cell Therapy Solution Product and Services
Table 86. Sorrento Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sorrento Therapeutics Recent Developments/Updates
Table 88. Gilead Sciences Basic Information, Area Served and Competitors
Table 89. Gilead Sciences Major Business
Table 90. Gilead Sciences CAR-T Cell Therapy Solution Product and Services
Table 91. Gilead Sciences CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of CAR-T Cell Therapy Solution Upstream (Raw Materials)
Table 93. CAR-T Cell Therapy Solution Typical Customers
List of Figure
Figure 1. CAR-T Cell Therapy Solution Picture
Figure 2. World CAR-T Cell Therapy Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CAR-T Cell Therapy Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 13. CAR-T Cell Therapy Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World CAR-T Cell Therapy Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CAR-T Cell Therapy Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR-T Cell Therapy Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR-T Cell Therapy Solution Markets in 2022
Figure 27. United States VS China: CAR-T Cell Therapy Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CAR-T Cell Therapy Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CAR-T Cell Therapy Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CAR-T Cell Therapy Solution Market Size Market Share by Type in 2022
Figure 31. CD19 CAR Cell Therapy
Figure 32. BCMA CAR Cell Therapy
Figure 33. World CAR-T Cell Therapy Solution Market Size Market Share by Type (2018-2029)
Figure 34. World CAR-T Cell Therapy Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CAR-T Cell Therapy Solution Market Size Market Share by Application in 2022
Figure 36. Leukemia
Figure 37. Lymphoma
Figure 38. Myeloma
Figure 39. Others
Figure 40. CAR-T Cell Therapy Solution Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global CAR-T Cell Therapy Solution Supply, Demand and Key Producers, 2023-2029

Global CAR-T Cell Therapy Solution Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 04 Apr 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global CAR-T Cell Therapy Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global CAR-T Cell Therapy Solution demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CAR-T Cell Therapy Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR-T Cell Therapy Solution that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CAR-T Cell Therapy Solution total market, 2018-2029, (USD Million)
Global CAR-T Cell Therapy Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CAR-T Cell Therapy Solution total market, key domestic companies and share, (USD Million)
Global CAR-T Cell Therapy Solution revenue by player and market share 2018-2023, (USD Million)
Global CAR-T Cell Therapy Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global CAR-T Cell Therapy Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global CAR-T Cell Therapy Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Q2 Solutions, Agilent Technologies, Genscript Biotech, Sino Biological, Nuowei Biotechnology, Novartis, JW Therapeutics and Sorrento Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR-T Cell Therapy Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global CAR-T Cell Therapy Solution Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global CAR-T Cell Therapy Solution Market, Segmentation by Type
CD19 CAR Cell Therapy
BCMA CAR Cell Therapy

Global CAR-T Cell Therapy Solution Market, Segmentation by Application
Leukemia
Lymphoma
Myeloma
Others

Companies Profiled:
Thermo Fisher Scientific
Q2 Solutions
Agilent Technologies
Genscript Biotech
Sino Biological
Nuowei Biotechnology
Novartis
JW Therapeutics
Sorrento Therapeutics
Gilead Sciences

Key Questions Answered
1. How big is the global CAR-T Cell Therapy Solution market?
2. What is the demand of the global CAR-T Cell Therapy Solution market?
3. What is the year over year growth of the global CAR-T Cell Therapy Solution market?
4. What is the total value of the global CAR-T Cell Therapy Solution market?
5. Who are the major players in the global CAR-T Cell Therapy Solution market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 CAR-T Cell Therapy Solution Introduction
1.2 World CAR-T Cell Therapy Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World CAR-T Cell Therapy Solution Total Market by Region (by Headquarter Location)
1.3.1 World CAR-T Cell Therapy Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.3 China CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.4 Europe CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.5 Japan CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.6 South Korea CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.7 ASEAN CAR-T Cell Therapy Solution Market Size (2018-2029)
1.3.8 India CAR-T Cell Therapy Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CAR-T Cell Therapy Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CAR-T Cell Therapy Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.2 World CAR-T Cell Therapy Solution Consumption Value by Region
2.2.1 World CAR-T Cell Therapy Solution Consumption Value by Region (2018-2023)
2.2.2 World CAR-T Cell Therapy Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.4 China CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.5 Europe CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.6 Japan CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.7 South Korea CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.8 ASEAN CAR-T Cell Therapy Solution Consumption Value (2018-2029)
2.9 India CAR-T Cell Therapy Solution Consumption Value (2018-2029)

3 World CAR-T Cell Therapy Solution Companies Competitive Analysis
3.1 World CAR-T Cell Therapy Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CAR-T Cell Therapy Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CAR-T Cell Therapy Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for CAR-T Cell Therapy Solution in 2022
3.3 CAR-T Cell Therapy Solution Company Evaluation Quadrant
3.4 CAR-T Cell Therapy Solution Market: Overall Company Footprint Analysis
3.4.1 CAR-T Cell Therapy Solution Market: Region Footprint
3.4.2 CAR-T Cell Therapy Solution Market: Company Product Type Footprint
3.4.3 CAR-T Cell Therapy Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: CAR-T Cell Therapy Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CAR-T Cell Therapy Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: CAR-T Cell Therapy Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: CAR-T Cell Therapy Solution Consumption Value Comparison
4.2.1 United States VS China: CAR-T Cell Therapy Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CAR-T Cell Therapy Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based CAR-T Cell Therapy Solution Companies and Market Share, 2018-2023
4.3.1 United States Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023)
4.4 China Based Companies CAR-T Cell Therapy Solution Revenue and Market Share, 2018-2023
4.4.1 China Based CAR-T Cell Therapy Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023)
4.5 Rest of World Based CAR-T Cell Therapy Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World CAR-T Cell Therapy Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19 CAR Cell Therapy
5.2.2 BCMA CAR Cell Therapy
5.3 Market Segment by Type
5.3.1 World CAR-T Cell Therapy Solution Market Size by Type (2018-2023)
5.3.2 World CAR-T Cell Therapy Solution Market Size by Type (2024-2029)
5.3.3 World CAR-T Cell Therapy Solution Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World CAR-T Cell Therapy Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Leukemia
6.2.2 Lymphoma
6.2.3 Myeloma
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World CAR-T Cell Therapy Solution Market Size by Application (2018-2023)
6.3.2 World CAR-T Cell Therapy Solution Market Size by Application (2024-2029)
6.3.3 World CAR-T Cell Therapy Solution Market Size by Application (2018-2029)

7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific CAR-T Cell Therapy Solution Product and Services
7.1.4 Thermo Fisher Scientific CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Q2 Solutions
7.2.1 Q2 Solutions Details
7.2.2 Q2 Solutions Major Business
7.2.3 Q2 Solutions CAR-T Cell Therapy Solution Product and Services
7.2.4 Q2 Solutions CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Q2 Solutions Recent Developments/Updates
7.2.6 Q2 Solutions Competitive Strengths & Weaknesses
7.3 Agilent Technologies
7.3.1 Agilent Technologies Details
7.3.2 Agilent Technologies Major Business
7.3.3 Agilent Technologies CAR-T Cell Therapy Solution Product and Services
7.3.4 Agilent Technologies CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Agilent Technologies Recent Developments/Updates
7.3.6 Agilent Technologies Competitive Strengths & Weaknesses
7.4 Genscript Biotech
7.4.1 Genscript Biotech Details
7.4.2 Genscript Biotech Major Business
7.4.3 Genscript Biotech CAR-T Cell Therapy Solution Product and Services
7.4.4 Genscript Biotech CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Genscript Biotech Recent Developments/Updates
7.4.6 Genscript Biotech Competitive Strengths & Weaknesses
7.5 Sino Biological
7.5.1 Sino Biological Details
7.5.2 Sino Biological Major Business
7.5.3 Sino Biological CAR-T Cell Therapy Solution Product and Services
7.5.4 Sino Biological CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sino Biological Recent Developments/Updates
7.5.6 Sino Biological Competitive Strengths & Weaknesses
7.6 Nuowei Biotechnology
7.6.1 Nuowei Biotechnology Details
7.6.2 Nuowei Biotechnology Major Business
7.6.3 Nuowei Biotechnology CAR-T Cell Therapy Solution Product and Services
7.6.4 Nuowei Biotechnology CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Nuowei Biotechnology Recent Developments/Updates
7.6.6 Nuowei Biotechnology Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis CAR-T Cell Therapy Solution Product and Services
7.7.4 Novartis CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 JW Therapeutics
7.8.1 JW Therapeutics Details
7.8.2 JW Therapeutics Major Business
7.8.3 JW Therapeutics CAR-T Cell Therapy Solution Product and Services
7.8.4 JW Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 JW Therapeutics Recent Developments/Updates
7.8.6 JW Therapeutics Competitive Strengths & Weaknesses
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Details
7.9.2 Sorrento Therapeutics Major Business
7.9.3 Sorrento Therapeutics CAR-T Cell Therapy Solution Product and Services
7.9.4 Sorrento Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sorrento Therapeutics Recent Developments/Updates
7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
7.10 Gilead Sciences
7.10.1 Gilead Sciences Details
7.10.2 Gilead Sciences Major Business
7.10.3 Gilead Sciences CAR-T Cell Therapy Solution Product and Services
7.10.4 Gilead Sciences CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Gilead Sciences Recent Developments/Updates
7.10.6 Gilead Sciences Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 CAR-T Cell Therapy Solution Industry Chain
8.2 CAR-T Cell Therapy Solution Upstream Analysis
8.3 CAR-T Cell Therapy Solution Midstream Analysis
8.4 CAR-T Cell Therapy Solution Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World CAR-T Cell Therapy Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World CAR-T Cell Therapy Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World CAR-T Cell Therapy Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CAR-T Cell Therapy Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World CAR-T Cell Therapy Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World CAR-T Cell Therapy Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World CAR-T Cell Therapy Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key CAR-T Cell Therapy Solution Players in 2022
Table 12. World CAR-T Cell Therapy Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global CAR-T Cell Therapy Solution Company Evaluation Quadrant
Table 14. Head Office of Key CAR-T Cell Therapy Solution Player
Table 15. CAR-T Cell Therapy Solution Market: Company Product Type Footprint
Table 16. CAR-T Cell Therapy Solution Market: Company Product Application Footprint
Table 17. CAR-T Cell Therapy Solution Mergers & Acquisitions Activity
Table 18. United States VS China CAR-T Cell Therapy Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China CAR-T Cell Therapy Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies CAR-T Cell Therapy Solution Revenue Market Share (2018-2023)
Table 23. China Based CAR-T Cell Therapy Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies CAR-T Cell Therapy Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based CAR-T Cell Therapy Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CAR-T Cell Therapy Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies CAR-T Cell Therapy Solution Revenue Market Share (2018-2023)
Table 29. World CAR-T Cell Therapy Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World CAR-T Cell Therapy Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World CAR-T Cell Therapy Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World CAR-T Cell Therapy Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World CAR-T Cell Therapy Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World CAR-T Cell Therapy Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific CAR-T Cell Therapy Solution Product and Services
Table 38. Thermo Fisher Scientific CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Q2 Solutions Basic Information, Area Served and Competitors
Table 42. Q2 Solutions Major Business
Table 43. Q2 Solutions CAR-T Cell Therapy Solution Product and Services
Table 44. Q2 Solutions CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Q2 Solutions Recent Developments/Updates
Table 46. Q2 Solutions Competitive Strengths & Weaknesses
Table 47. Agilent Technologies Basic Information, Area Served and Competitors
Table 48. Agilent Technologies Major Business
Table 49. Agilent Technologies CAR-T Cell Therapy Solution Product and Services
Table 50. Agilent Technologies CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Agilent Technologies Recent Developments/Updates
Table 52. Agilent Technologies Competitive Strengths & Weaknesses
Table 53. Genscript Biotech Basic Information, Area Served and Competitors
Table 54. Genscript Biotech Major Business
Table 55. Genscript Biotech CAR-T Cell Therapy Solution Product and Services
Table 56. Genscript Biotech CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Genscript Biotech Recent Developments/Updates
Table 58. Genscript Biotech Competitive Strengths & Weaknesses
Table 59. Sino Biological Basic Information, Area Served and Competitors
Table 60. Sino Biological Major Business
Table 61. Sino Biological CAR-T Cell Therapy Solution Product and Services
Table 62. Sino Biological CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sino Biological Recent Developments/Updates
Table 64. Sino Biological Competitive Strengths & Weaknesses
Table 65. Nuowei Biotechnology Basic Information, Area Served and Competitors
Table 66. Nuowei Biotechnology Major Business
Table 67. Nuowei Biotechnology CAR-T Cell Therapy Solution Product and Services
Table 68. Nuowei Biotechnology CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Nuowei Biotechnology Recent Developments/Updates
Table 70. Nuowei Biotechnology Competitive Strengths & Weaknesses
Table 71. Novartis Basic Information, Area Served and Competitors
Table 72. Novartis Major Business
Table 73. Novartis CAR-T Cell Therapy Solution Product and Services
Table 74. Novartis CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novartis Recent Developments/Updates
Table 76. Novartis Competitive Strengths & Weaknesses
Table 77. JW Therapeutics Basic Information, Area Served and Competitors
Table 78. JW Therapeutics Major Business
Table 79. JW Therapeutics CAR-T Cell Therapy Solution Product and Services
Table 80. JW Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. JW Therapeutics Recent Developments/Updates
Table 82. JW Therapeutics Competitive Strengths & Weaknesses
Table 83. Sorrento Therapeutics Basic Information, Area Served and Competitors
Table 84. Sorrento Therapeutics Major Business
Table 85. Sorrento Therapeutics CAR-T Cell Therapy Solution Product and Services
Table 86. Sorrento Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sorrento Therapeutics Recent Developments/Updates
Table 88. Gilead Sciences Basic Information, Area Served and Competitors
Table 89. Gilead Sciences Major Business
Table 90. Gilead Sciences CAR-T Cell Therapy Solution Product and Services
Table 91. Gilead Sciences CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of CAR-T Cell Therapy Solution Upstream (Raw Materials)
Table 93. CAR-T Cell Therapy Solution Typical Customers
List of Figure
Figure 1. CAR-T Cell Therapy Solution Picture
Figure 2. World CAR-T Cell Therapy Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CAR-T Cell Therapy Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World CAR-T Cell Therapy Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company CAR-T Cell Therapy Solution Revenue (2018-2029) & (USD Million)
Figure 13. CAR-T Cell Therapy Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World CAR-T Cell Therapy Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India CAR-T Cell Therapy Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of CAR-T Cell Therapy Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR-T Cell Therapy Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR-T Cell Therapy Solution Markets in 2022
Figure 27. United States VS China: CAR-T Cell Therapy Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CAR-T Cell Therapy Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World CAR-T Cell Therapy Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World CAR-T Cell Therapy Solution Market Size Market Share by Type in 2022
Figure 31. CD19 CAR Cell Therapy
Figure 32. BCMA CAR Cell Therapy
Figure 33. World CAR-T Cell Therapy Solution Market Size Market Share by Type (2018-2029)
Figure 34. World CAR-T Cell Therapy Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World CAR-T Cell Therapy Solution Market Size Market Share by Application in 2022
Figure 36. Leukemia
Figure 37. Lymphoma
Figure 38. Myeloma
Figure 39. Others
Figure 40. CAR-T Cell Therapy Solution Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now